Short Interest in Aditxt, Inc. (NASDAQ:ADTX) Grows By 7,665.5%

Aditxt, Inc. (NASDAQ:ADTX) was the recipient of a significant growth in short interest during the month of October. As of October 15th, there was short interest totalling 450,400 shares, a growth of 7,665.5% from the September 30th total of 5,800 shares. Based on an average daily volume of 1,810,000 shares, the days-to-cover ratio is currently 0.2 days. Currently, 10.7% of the company’s stock are short sold.

Aditxt Stock Performance

Shares of Aditxt stock opened at $0.84 on Friday. Aditxt has a twelve month low of $0.76 and a twelve month high of $380.00. The company’s 50 day moving average is $13.88 and its 200 day moving average is $51.96.

Aditxt (NASDAQ:ADTX) last announced its earnings results on Monday, August 19th. The company reported ($167.60) earnings per share for the quarter. The business had revenue of $0.04 million for the quarter.

Insider Transactions at Aditxt

In related news, major shareholder Financial Lp Hrt sold 25,534 shares of the stock in a transaction on Wednesday, October 16th. The stock was sold at an average price of $1.17, for a total transaction of $29,874.78. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Company insiders own 1.23% of the company’s stock.

Aditxt Company Profile

Aditxt, Inc, a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues.